Mary K. Danks

Phase II study of oxaliplatin in children with recurrent or refractory medulloblastoma, supratentorial primitive neuroectodermal tumors, and atypical teratoid rhabdoid tumors

R. McLendon, C. Fuller, M. Danks, 2006, Cancer.

New therapeutic targets for the treatment of high‐risk neuroblastoma

M. Danks, L. Wagner, Mary K. Danks, 2009, Journal of cellular biochemistry.

Multiple mechanisms of resistance in a series of human testicular teratoma cell lines selected for increasing resistance to etoposide

I. Hickson, B. Hill, M. Danks, 1994, International journal of cancer.